Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 20, Issue 29, Pages 9675
Publisher
Baishideng Publishing Group Inc.
Online
2014-08-11
DOI
10.3748/wjg.v20.i29.9675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 566 Infliximab Concentration and Clinical Outcome in Patients With Ulcerative Colitis
- (2015) Walter Reinisch et al. GASTROENTEROLOGY
- Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
- (2013) R. Panaccione et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines
- (2013) J. D. Feuerstein et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab in active ulcerative colitis: A “real-life” observational study
- (2013) Alessandro Armuzzi et al. DIGESTIVE AND LIVER DISEASE
- Topical Tacrolimus Therapy for Antibiotic-Refractory Pouchitis
- (2013) Motoi Uchino et al. DISEASES OF THE COLON & RECTUM
- Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations
- (2013) Ivanka Curkovic et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Temporary adalimumab dose escalation is effective in Crohn's disease patients with secondary non-response
- (2013) K. Sutharshan et al. Journal of Crohns & Colitis
- Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
- (2012) K. J. Schmidt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
- (2012) Solmaz Ehteshami-Afshar et al. Archives of Medical Science
- Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
- (2012) Shomron Ben–Horin et al. Clinical Gastroenterology and Hepatology
- Immunosuppression-Related Lymphomas and Cancers in IBD: How Can They Be Prevented?
- (2012) Laurent Beaugerie DIGESTIVE DISEASES
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease
- (2012) Casper Steenholdt et al. INFLAMMATORY BOWEL DISEASES
- Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy
- (2012) Lennard P.L. Gilissen et al. Journal of Crohns & Colitis
- Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study
- (2012) Filippo Mocciaro et al. Journal of Crohns & Colitis
- Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
- (2012) Axel Dignass et al. Journal of Crohns & Colitis
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- (2012) David Laharie et al. LANCET
- Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients
- (2011) Y. González-Lama et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: the role of tacrolimus in the management of Crohn’s disease
- (2011) K. McSharry et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis
- (2011) Helen French et al. DIGESTIVE DISEASES AND SCIENCES
- Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
- (2011) Harminder Singh et al. GASTROENTEROLOGY
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: A worldwide survey of experts
- (2011) Xavier Roblin et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab in steroid-dependent Crohnʼs disease patients: Prognostic factors for clinical benefit
- (2011) Ambrogio Orlando et al. INFLAMMATORY BOWEL DISEASES
- Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study
- (2011) Mats Sjöberg et al. INFLAMMATORY BOWEL DISEASES
- Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis
- (2011) Haruhiko Ogata et al. INFLAMMATORY BOWEL DISEASES
- Thalidomide Use and Outcomes in Pediatric Patients With Crohn Disease Refractory to Infliximab and Adalimumab
- (2011) Lina M. Felipez et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study
- (2010) A. Gustavsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
- (2010) C. Taxonera et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease
- (2010) Waqqas Afif et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatosplenic T-Cell Lymphoma in a Young Man With Crohn's Disease: Case Report and Literature Review
- (2010) Mark G. Ochenrider et al. Clinical Lymphoma Myeloma & Leukemia
- The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆
- (2010) Ambrogio Orlando et al. DIGESTIVE AND LIVER DISEASE
- Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis
- (2010) Adam S. Cheifetz et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
- (2010) A. Dignass et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cut-off levels and diagnostic accuracy of infliximab trough levels and anti-infliximab antibodies in Crohn's disease
- (2010) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
- (2009) M. WAHED et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
- (2009) Millie D. Long et al. Clinical Gastroenterology and Hepatology
- Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
- (2009) Konstantinos Karmiris et al. GASTROENTEROLOGY
- Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
- (2009) C H Seow et al. GUT
- Epstein–Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohnʼs disease
- (2009) C. Serrate et al. INFLAMMATORY BOWEL DISEASES
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis†
- (2009) Liliana Andrade Chebli et al. INFLAMMATORY BOWEL DISEASES
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Rectal tacrolimus in the treatment of resistant ulcerative proctitis
- (2008) I. C. LAWRANCE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience
- (2008) A. OUSSALAH et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis
- (2008) S. YAMAMOTO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
- (2008) U. HINDORF et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Hepatosplenic T cell lymphoma in inflammatory bowel disease
- (2008) M. Shale et al. GUT
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
- The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn’s disease
- (2008) Hiroyuki Tamaki et al. JOURNAL OF GASTROENTEROLOGY
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started